These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8974380)

  • 21. Enhancing the efficacy of 5-HT uptake inhibitors in the treatment of attention deficit hyperactivity disorder.
    Riley TB; Overton PG
    Med Hypotheses; 2019 Dec; 133():109407. PubMed ID: 31586811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism.
    Gianoulakis C
    J Psychiatry Neurosci; 2001 Sep; 26(4):304-18. PubMed ID: 11590970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neurobiology of alcoholism in genetically selected rat models.
    Stewart RB; Li TK
    Alcohol Health Res World; 1997; 21(2):169-76. PubMed ID: 15704355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluvoxamine and alcoholism.
    Thomas R
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():85-90; discussion 90-2. PubMed ID: 1806637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin and alcohol drinking.
    Sellers EM; Higgins GA; Tompkins DM; Romach MK
    NIDA Res Monogr; 1992; 119():141-5. PubMed ID: 1435969
    [No Abstract]   [Full Text] [Related]  

  • 26. Serotonin and alcohol intake, abuse, and dependence: findings of animal studies.
    LeMarquand D; Pihl RO; Benkelfat C
    Biol Psychiatry; 1994 Sep; 36(6):395-421. PubMed ID: 7803601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonergic agents and alcoholism treatment: rebirth of the subtype concept--an hypothesis.
    Johnson BA
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1597-601. PubMed ID: 11045870
    [No Abstract]   [Full Text] [Related]  

  • 28. Serotonergic Systems in the Pathophysiology of Ethanol Dependence: Relevance to Clinical Alcoholism.
    Marcinkiewcz CA
    ACS Chem Neurosci; 2015 Jul; 6(7):1026-39. PubMed ID: 25654315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rational approach to the pharmacotherapy of alcohol dependence.
    Petrakis IL
    J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S3-12. PubMed ID: 17114952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant trazodone in the treatment of alcoholism: an open study.
    Janiri L; Hadjichristos A; Buonanno A; Rago R; Mannelli P; de Risio S
    Alcohol Alcohol; 1998; 33(4):362-5. PubMed ID: 9719394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
    Anton RF
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):43-53. PubMed ID: 9845037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological challenge with a serotonin 1D agonist in alcohol dependence.
    Vythilingum B; Hugo CJ; Maritz JS; Pienaar W; Stein DJ
    BMC Psychiatry; 2005 Aug; 5():31. PubMed ID: 16120224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus conference on the neuropharmacology of alcohol dependence and the role of pharmacotherapy in its treatment. Amsterdam, The Netherlands, September 16-17, 1994.
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():1-87. PubMed ID: 8924128
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanisms of alcohol craving and their clinical implications.
    Singleton EG; Gorelick DA
    Recent Dev Alcohol; 1998; 14():177-95. PubMed ID: 9751946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Selective Serotonin Reuptake Inhibitors on Healthcare Utilization in Patients with Post-Traumatic Stress Disorder and Alcohol Use Disorder.
    Naglich AC; Bozeman S; Brown ES; Adinoff B
    Alcohol Alcohol; 2019 Jul; 54(4):428-434. PubMed ID: 31185085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive and negative reinforcement are differentially associated with alcohol consumption as a function of alcohol dependence.
    Cho SB; Su J; Kuo SI; Bucholz KK; Chan G; Edenberg HJ; McCutcheon VV; Schuckit MA; Kramer JR; Dick DM
    Psychol Addict Behav; 2019 Feb; 33(1):58-68. PubMed ID: 30667237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating readiness and treatment seeking effects in a pharmacotherapy trial for alcohol dependence.
    Penberthy JK; Ait-Daoud N; Breton M; Kovatchev B; DiClemente CC; Johnson BA
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1538-44. PubMed ID: 17624996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
    Maurel S; De Vry J; Schreiber R
    Alcohol; 1999 Apr; 17(3):195-201. PubMed ID: 10231167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder.
    Bahji A; Danilewitz M; Sloan M; Tang V; Crockford D
    CMAJ; 2024 Mar; 196(10):E346-E347. PubMed ID: 38499302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.